ArticleScientific reports2024

Integrating immune multi-omics and machine learning to improve prognosis, immune landscape, and sensitivity to first- and second-line treatments for head and neck squamous cell carcinoma.

Ji Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.